Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

Outcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy.

Fakhrian K, Ordu AD, Nieder C, Lordick F, Kup PG, Theisen J, Combs SE, Geinitz H.

Tumori. 2015 Apr 16;0(0):0. doi: 10.5301/tj.5000266. [Epub ahead of print]

PMID:
25908044
2.

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Lorenzen S, Riera Knorrenschild J, Haag GM, Pohl M, Thuss-Patience P, Bassermann F, Helbig U, Weißinger F, Schnoy E, Becker K, Stocker G, Rüschoff J, Eisenmenger A, Karapanagiotou-Schenkel I, Lordick F.

Eur J Cancer. 2015 Mar;51(5):569-76. doi: 10.1016/j.ejca.2015.01.059. Epub 2015 Feb 16.

PMID:
25694417
3.

Value of functional imaging by PET in esophageal cancer.

Schmidt T, Lordick F, Herrmann K, Ott K.

J Natl Compr Canc Netw. 2015 Feb;13(2):239-47. Review.

PMID:
25691614
4.

Effect of a structured psycho-oncological screening and treatment model on mental health in cancer patients (STEPPED CARE): study protocol for a cluster randomized controlled trial.

Singer S, Danker H, Briest S, Dietrich A, Dietz A, Einenkel J, Papsdorf K, Lordick F, Meixensberger J, Mössner J, Niederwieser D, Prietzel T, Schiefke F, Stolzenburg JU, Wirtz H, Kersting A.

Trials. 2014 Dec 10;15:482. doi: 10.1186/1745-6215-15-482.

5.

Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesis.

Lordick F.

Nat Rev Clin Oncol. 2015 Jan;12(1):7-8. doi: 10.1038/nrclinonc.2014.195. Epub 2014 Nov 18.

PMID:
25403941
6.

Proteomic and metabolic prediction of response to therapy in gastric cancer.

Aichler M, Luber B, Lordick F, Walch A.

World J Gastroenterol. 2014 Oct 14;20(38):13648-57. doi: 10.3748/wjg.v20.i38.13648.

7.

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.

Aichler M, Motschmann M, Jütting U, Luber B, Becker K, Ott K, Lordick F, Langer R, Feith M, Siewert JR, Walch A.

Oncotarget. 2014 Aug 30;5(16):6620-32.

8.

International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.

Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer HJ, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP.

Gastric Cancer. 2014 Sep 7. [Epub ahead of print]

PMID:
25192931
9.

Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.

Kuehnle MC, Attig S, Britten CM, Schulze-Bergkamen H, Lordick F, von Wichert G, Thuss-Patience P, Stein A, Schuler M, Bassermann F, Sahin U, Türeci O.

Cancer Immunol Immunother. 2014 Dec;63(12):1273-84. doi: 10.1007/s00262-014-1596-x. Epub 2014 Aug 28.

PMID:
25164876
10.

Mistletoe treatment for cancer--promising or passé?

Lordick F.

Dtsch Arztebl Int. 2014 Jul 21;111(29-30):491-2. doi: 10.3238/arztebl.2014.0493. No abstract available.

11.

Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.

Karamitopoulou E, Thies S, Zlobec I, Ott K, Feith M, Slotta-Huspenina J, Lordick F, Becker K, Langer R.

Am J Surg Pathol. 2014 Nov;38(11):1551-6. doi: 10.1097/PAS.0000000000000255.

PMID:
25140894
12.

[Incidence and treatment of chemotherapy-induced nausea and emesis in gastrointestinal cancer].

Lorenzen S, Spörl S, Lordick F.

Z Gastroenterol. 2014 Aug;52(8):821-30. doi: 10.1055/s-0034-1366774. Epub 2014 Aug 11. German.

PMID:
25111723
13.

Rectal cancer with synchronous liver metastases: leave it all in? When (not) to resect the primary?

Lordick F.

Recent Results Cancer Res. 2014;203:231-41. doi: 10.1007/978-3-319-08060-4_16.

PMID:
25103009
14.

Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution.

Fakhrian K, Ordu AD, Lordick F, Theisen J, Haller B, Omrčen T, Molls M, Nieder C, Geinitz H.

Strahlenther Onkol. 2014 Nov;190(12):1133-40.

PMID:
25015426
15.

Targeting the HGF/MET pathway in gastric cancer.

Lordick F.

Lancet Oncol. 2014 Aug;15(9):914-6. doi: 10.1016/S1470-2045(14)70273-6. Epub 2014 Jun 22. No abstract available.

PMID:
24965570
16.

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study.

Sehouli J, Pietzner K, Wimberger P, Vergote I, Rosenberg P, Schneeweiss A, Bokemeyer C, Salat C, Scambia G, Berton-Rigaud D, Santoro A, Cervantes A, Trédan O, Tournigand C, Colombo N, Dudnichenko AS, Westermann A, Friccius-Quecke H, Lordick F.

Med Oncol. 2014 Aug;31(8):76. doi: 10.1007/s12032-014-0076-7. Epub 2014 Jun 26.

PMID:
24965536
17.

Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.

Boehm A, Lindner F, Wichmann G, Bauer U, Wittekind C, Knoedler M, Lordick F, Dietzsch S, Scholz M, Kortmann R, Dietz A.

Eur Arch Otorhinolaryngol. 2014 Jun 25. [Epub ahead of print]

PMID:
24961436
18.

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond.

Gomez-Martín C, Lopez-Rios F, Aparicio J, Barriuso J, García-Carbonero R, Pazo R, Rivera F, Salgado M, Salud A, Vázquez-Sequeiros E, Lordick F.

Cancer Lett. 2014 Aug 28;351(1):30-40. doi: 10.1016/j.canlet.2014.05.019. Epub 2014 Jun 3. Review.

PMID:
24943493
19.

[Importance of PET in surgery of esophageal cancer].

Ott K, Schmidt T, Lordick F, Herrmann K.

Chirurg. 2014 Jun;85(6):505-12. doi: 10.1007/s00104-013-2668-8. German.

PMID:
24817185
20.

Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases.

Homayounfar K, Bleckmann A, Helms HJ, Lordick F, Rüschoff J, Conradi LC, Sprenger T, Ghadimi M, Liersch T.

Br J Surg. 2014 Apr;101(5):550-7. doi: 10.1002/bjs.9436. Epub 2014 Feb 20.

PMID:
24756914
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk